Keep me logged in for 24 hours

Register new account
I forgot my password

Welcome to BAP

 
Search Journal Search All SAGE Journals
Current OnlineFirst

The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

BAP endorses the Fact Sheet on Ketamine Scheduling

Fact Sheet on Ketamine Scheduling (updated 27 Feb 2015)
Extended Fact Sheet on Ketamine Scheduling
Members of CND
International Federation of Red Cross and Red Crescent (IFRC) position paper
Schedule II and IV requirements
Essential veterinary use of ketamine

Read Professor David Nutt's article on the ketamine ban

Update 24 February – in response to a letter from BAP, the Chief Medical Officer, Professor Dame Sally Davies, replies “I would like to assure you that the UK Government supports the continued medical and scientific use of ketamine for the reasons that you have set out. The UK Government will make this point in international fora as appropriate, and will not support its scheduling under the international drug conventions.”

Update 27 February – the final version of the fact sheet and additional advocacy documents are now available to download (above).

Where is the BAP Stand?

Below is a list of events where the BAP stand will be:

RCPsych Faculty of General Adult Psychiatry Annual Conference 8th October 2015 - 9th October 2015 Millennium Gloucester Hotel & Conference Centre, London

Members' Activities


Stephen Lawrie
The War On Drugs Is Harmful

Stephen talks about the war on drugs at the Edinburgh Fringe Festival.
24th August 2015

Jonathan Roiser
Depression treatment – the way forward

Jonathan talks to Lynne Malcolm of Australian Radio National to talk about depression and the brain for 'All in the mind'
9th August 2015

Jeff Nye
Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary

Jeff co-organised a symposium on science and policy issues in non-invasive neurostimulation and the Institute of Medicine released a report.
27th July 2015

See more Members' Activities


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.

Latest News

Subscribe to the News Feed rss feed

  1. Summer Meeting 2015 – Wednesday Symposium 9
    on 31st July 2015

    David Troy reports from Symposium 9 – 'Non-invasive Neurostimulation'
    Read Article
  2. Summer Meeting 2015 – Wednesday Symposium 8
    on 31st July 2015

    Abigail Moss attended Wednesday’s Symposium 8 – ‘The role of synaptic proteins in schizophrenia and related neurodevelopmental disorders’
    Read Report
  3. Summer Meeting 2015 – Wednesday Symposium 7
    on 31st July 2015

    Michael Dalili attended Symposium 7 – 'Advances in Compulsivity: A trans-diagnostic perspective'
    Read Report

See more news